Development of a rapid risk evaluation tool for herbs/drugs interactions in cancer patients: a multicentric experience in south of France
Authors:
- 7 September 2017
- journal article
- research article
- Published by Wiley in European Journal of Cancer Care
- Vol. 26 (6) , e12752
Abstract
Cancer patients use herbs in spite of severe interactions risks with major anticancer drugs. In daily practice, it is very difficult for oncologists to detect and define the risk of a herb-anticancer drug interaction (HDI). In this work, we realised a state of play in one of the most populated region of France by evaluating, through a specific questionnaire, the position of a representative panel of oncologists. About 80% of them thought that herbs interact with anticancer treatments whereas only 15.4% of them actually knew the real HDI. About 89.1% of them thought that a practical detection tool would be relevant and useful for their daily practice. Then, we constructed a tool in order to rapidly evaluate a HDI risk level. Based on experts’ reviews and using a criticality matrix, we determined the HDI risk level between 11 herbs and 126 anticancer drugs. Then, we measured satisfactory of oncologists. All of them considered the tool as useful in their daily practice and then used it. This work highlighted that even if HDI has been integrated as a theoretical risk, its practical detection and risk evaluation is difficult to implement for oncologists in their daily practice. Thus, the tool we developed should answer to an unmet medical need.Keywords
This publication has 40 references indexed in Scilit:
- Use of Complementary and Alternative Medicine in Patients with Gynecologic Cancer: a Systematic ReviewAsian Pacific Journal of Cancer Prevention, 2015
- Herb–Drug Interactions: Challenges and Opportunities for Improved PredictionsDrug Metabolism and Disposition, 2014
- Probable Etoposide Interaction withEchinaceaJournal of Dietary Supplements, 2012
- Complementary medicine use by men with prostate cancer: a systematic review of prevalence studiesProstate Cancer and Prostatic Diseases, 2010
- Evidence-Based Management of Herb-Drug Interaction in Cancer ChemotherapyEXPLORE, 2010
- Imatinib and Panax Ginseng : A Potential Interaction Resulting in Liver ToxicityAnnals of Pharmacotherapy, 2010
- Prevalence of Complementary Medicine Use in Pediatric Cancer: A Systematic ReviewPediatrics, 2010
- Garlic (Allium sativum L.): Adverse effects and drug interactions in humansMolecular Nutrition & Food Research, 2007
- Evidence-based drug–herbal interactionsLife Sciences, 2006
- Drug interactions in oncologyThe Lancet Oncology, 2004